Obesity, energy balance, and cancer: new opportunities for prevention
- PMID: 23034147
- PMCID: PMC3641761
- DOI: 10.1158/1940-6207.CAPR-12-0140
Obesity, energy balance, and cancer: new opportunities for prevention
Abstract
Obesity is associated with increased risk and poor prognosis for many types of cancer. The mechanisms underlying the obesity-cancer link are becoming increasingly clear and provide multiple opportunities for primary to tertiary prevention. Several obesity-related host factors can influence tumor initiation, progression and/or response to therapy, and these have been implicated as key contributors to the complex effects of obesity on cancer incidence and outcomes. These host factors include insulin, insulin-like growth factor-I, leptin, adiponectin, steroid hormones, cytokines, and inflammation-related molecules. Each of these host factors is considered in the context of energy balance and as potential targets for cancer prevention. The possibility of prevention at the systems level, including energy restriction, dietary composition, and exercise is considered as is the importance of the newly emerging field of stem cell research as a model for studying energy balance and cancer prevention.
Figures
References
-
- [Accessed February 6, 2011.];WHO fact sheet 311. http://www.who.int/mediacentre/factsheets/fs311/en/
-
- Calle EE, Kaaks R. Overweight, Obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91. - PubMed
-
- Ballard-Barbash R, Berrigan D, Potischman N, Dowling E. Obesity and Cancer Epidemiology. In: Berger NA, editor. Energy Balance and Cancer. Springer; 2010. pp. 1–44.
-
- Nock NL. Obesity and Gastrointestinal Cancers: Epidemiology. In: Markowitz SD, Berger Na, editors. Energy Balance and Gastrointestinal Cancer. Springer; 2012. pp. 1–22.
-
- Teras LR, Patel AV. The Epidemiology of Obesity and Hematologic Malignancies. In: Mittelman SD, Berger NA, editors. Energy Balance and Hematologic Malignancies. Springer; 2012. pp. 1–30.
Publication types
MeSH terms
Substances
Grants and funding
- R01CA154481/CA/NCI NIH HHS/United States
- R01 CA037111/CA/NCI NIH HHS/United States
- R01CA129409/CA/NCI NIH HHS/United States
- R01CA128700/CA/NCI NIH HHS/United States
- R01CA062483/CA/NCI NIH HHS/United States
- P30 CA013148/CA/NCI NIH HHS/United States
- K07 CA128884/CA/NCI NIH HHS/United States
- P30ES007784/ES/NIEHS NIH HHS/United States
- R25 CA047888/CA/NCI NIH HHS/United States
- U54 CA116867/CA/NCI NIH HHS/United States
- P30 ES007784/ES/NIEHS NIH HHS/United States
- R01 CA129409/CA/NCI NIH HHS/United States
- P30 CA014236/CA/NCI NIH HHS/United States
- R01 CA154481/CA/NCI NIH HHS/United States
- KO7CA128884/CA/NCI NIH HHS/United States
- R01 CA062483/CA/NCI NIH HHS/United States
- R01CA037111/CA/NCI NIH HHS/United States
- P30 CA13148/CA/NCI NIH HHS/United States
- P40 RR012305/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
